Why Is There a Shortage of HRT Patches?
Shortages of hormone replacement therapy patches have been reported in several countries, often linked to manufacturing delays, supply chain disruptions, and increased demand. Regulatory bodies and pharmacies track these issues and update lists of affected products and strengths.
Which HRT Patches Are Affected?
Common brands such as Estradot and Evorel have faced intermittent supply problems in some regions. Shortages can vary by dose, formulation, and pharmacy chain. Patients are advised to check with their pharmacist or prescriber for current availability and suitable alternatives.
What Can Patients Do During a Shortage?
Healthcare providers may recommend switching to a different brand, changing the delivery method, or adjusting the dose temporarily. Patients should not stop treatment without medical guidance. Pharmacists can help locate remaining stock or suggest clinically appropriate options.
Where to Get Updated Information
Official health agencies and medicines regulators publish shortage alerts and guidance. In the United States, the FDA maintains a drug shortage database with details on HRT products. In the United Kingdom, the MHRA and NHS services provide updates on availability and prescribing advice.
